M. Hope
Molecular Biology · 2010–2019
A researcher in the Science corpus: 7 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 37 citations into it
Whom M. Hope trusts
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from M. Hope's perspective
Ordered by how strongly the researchers M. Hope trusts endorse each paper. Same corpus, a different order for every researcher.
- A combinatorial library of lipid-like materials for delivery of RNAi therapeutics (Nature Biotechnology)
- Toxicity of cationic lipids and cationic polymers in gene delivery. (Journal of Controlled Release)
- Zika virus protection by a single low dose nucleoside modified mRNA vaccination (Nature)
- Safety and efficacy of RNAi therapy for transthyretin amyloidosis. (New England Journal of Medicine)
- Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape (Nature Biotechnology)
- Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. (Journal of Controlled Release)
- Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA (Molecular Therapy: Nucleic Acids)
- Drug Delivery Systems: Entering the Mainstream (Science)
- Inhibition of respiratory viruses by nasally administered siRNA (Nature Medicine)
- Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors (Nature Biotechnology)
Their papers
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms. (2010) — 955 citations
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes (2015) — 893 citations
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo (2012) — 1,185 citations
- Rational design of cationic lipids for siRNA delivery (2010) — 1,657 citations
- The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs (2019) — 1,342 citations
- Lipid Nanoparticle Systems for Enabling Gene Therapies. (2017) — 1,006 citations
- Zika virus protection by a single low dose nucleoside modified mRNA vaccination (2017) — 808 citations